The Translational Medicine Business Summit 2013 is dedicated to RNA-based translational research and commercial activities with a focus on business opportunities and challenges in RNA-based translational medicine, including:
- Personalized Medicine Focused on RNAs
- Challenges in RNA Translational Research
- Diagnostics Development Focused on RNAs
- Biomarker Development Focused on RNAs
Topics include:
- Epigenetic Biomarkers
- Companion Diagnostics
- MRNA Biomarkers
- MicroRNA Biomarkers
- Protein Biomarkers
- Next-Generation Sequencing (NGS) for Harvesting RNA Biomarkers
- RNAi-based Therapeutics
The Translational Medicine Business Summit 2013 brings together:
- Researchers Focusing on Translational Activities
- Business Development Leaders from Biotech, Pharma and Academic Institutions
- Licensing Executives in the Biomarker and Diagnostics Fields